Table 2 |
||||
|
Odds ratios for the metabolic syndrome (NCEP III) in comparison with the amount of steroid exposure |
||||
| LD/LTE |
MD/LTE |
|||
|
|
|
|||
| OR (95% CI) |
P value |
OR (95% CI) |
P value |
|
|
|
||||
| Crude |
1.13 (0.62–2.04) |
0.695 |
1.64 (0.92–2.92) |
0.094 |
| Model a |
0.998 (0.54–1.83) |
0.994 |
1.37 (0.75–2.48) |
0.304 |
| Model b |
1.15 (0.61–2.19) |
0.670 |
1.4 (0.72–2.58) |
0.340 |
|
|
||||
|
Crude = uncorrected data. Model a = crude data plus adjustment for age and gender. Model b = model a plus adjustment for markers of disease activity/severity (disease duration, erythrocyte sedimentation rate levels, and health assessment questionnaire). CI, confidence interval; LD/LTE, low-dose/long-term exposure; MD/LTE, moderate-dose/long-term exposure; NCEP III, National Cholesterol Education Programme III; OR, odds ratio. |
||||
|
Toms et al. Arthritis Research & Therapy 2008 10:R145 doi:10.1186/ar2578 |
||||
